MedTrace Logo

Effects of A-GPC on Reaction Time and Cognitive Function

NCT03903250 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2020-11-12

No results posted yet for this study

Summary

This is a randomized, double blind, crossover design study which measures the effect of alpha-glycerylphosphorylcholine (A-GPC) on reaction time and cognitive function in non-resistance trained males and females. Participants will complete baseline testing and then be randomized into one of two crossover treatments. Participants will report to the lab for five consecutive days whilst only getting a maximum of five hours of sleep per night from Monday through Thursday night. Once testing is complete on Friday, participants will receive a one week washout period then return to complete the opposite treatment.

Conditions

  • Cognitive Change
  • Reaction Time

Interventions

DIETARY_SUPPLEMENT

A-GPC

Taken orally in liquid form

DIETARY_SUPPLEMENT

Sugar

Taken orally in liquid form

Sponsors & Collaborators

  • Chemi Nutra, LLC.

    collaborator UNKNOWN

  • University of Mary Hardin-Baylor

    lead OTHER

Principal Investigators

  • Lemuel W Taylor IV, PhD · UMHB Human Performance Lab

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-03-25
Primary Completion
2020-09-18
Completion
2020-09-18

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03903250 on ClinicalTrials.gov